You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Sun Pharma operates in several business segments including generics, branded generics, specialty, active pharmaceutical ingredients (APIs), and consumer healthcare products. The company also focuses on emerging markets and the US market for its expansive generic portfolio. |
Business Models for Each Product Line |
Sun Pharma generates revenue through the sale of generic and branded pharmaceutical products. The generics segment relies on high-volume sales at competitive prices, whereas the specialty segment focuses on innovative treatments that enable premium pricing. Revenue from APIs is derived from supplying active ingredients to other pharmaceutical companies. Expenses majorly include research and development, manufacturing, marketing, and distribution costs. |
Future Opportunities for Growth |
Sun Pharma is pursuing growth through innovation in specialty treatments, expanding its presence in emerging markets, and enhancing its generics portfolio. The company is also investing in biosimilars and strengthening its pipeline through strategic acquisitions and partnerships. |
Potential Major Risks |
Major risks include regulatory challenges in different markets, intense competition in the generic space, potential litigation related to patents and pricing, and fluctuating currencies impacting revenues from international markets. |
Learn More about Sun Pharma:
Company Insights by Algobear (ChatGPT);
Tell me more about Sun Pharma's latest earnings (SUNPHARMA:Nse)
Who are some of Sun Pharma's competitors? (SUNPHARMA:Nse)
Are analysts bullish on Sun Pharma? Please show it in a table format. (SUNPHARMA:Nse)
Also read:
https://finance.yahoo.com/SUNPHARMA.NS/profile
Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Quarterly Earnings Growth | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Operating Cash Flow-Display | Levered Free Cash Flow-Display | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4.2 lakh cr | 4200000000000.0 | 420000.0 | 4.02 lakh cr | 4020000000000.0 | 402000.0 | 36.72 | 26.95 | 8.22 | 6.08 | 7.88 | 24.92 | 22.16% | 26.05% | 51602.0 Cr | 516020000000.0 | 51602.0 | 10.50% | 14644.0 Cr | 146440000000.0 | 14644.0 | 47.64 | 15.00% | 20122.0 Cr | 201220000000.0 | 20122.0 | 2572.0 Cr | 25720000000.0 | 2572.0 | 0.0371 | nan Cr | nan Cr | 55.50% | 25.33% |
source:https://finance.yahoo.com/SUNPHARMA.NS/key-statistics
source:https://finance.yahoo.com/SUNPHARMA.NS/key-statistics
source:https://www.google.com/finance/quote/SUNPHARMA:NSE
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 3.11% | 1.46% (1807.9) | 2.14% (1820) | 3.44% (1843.1) | 7.96% (1923.65) | 10.02% (1960.35) | 10.02% (1960.35) | 10.02% (1960.35) |
Downside % (low) | 11.13% | 5.3% (1687.4) | 9.08% (1620.1) | 12.84% (1553.05) | 12.84% (1553.05) | 22.71% (1377.2) | 55.67% (789.9) | 82.49% (312) |
Spread % | -8.01% | -3.83% | -6.93% | -9.4% | -4.88% | -12.69% | -45.65% | -72.47% |
SUNPHARMA's price used for computing the stats is 1781.8 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | -1.23% | 5.24% | 6.93% | 2.85% | 1.42% | -5.61% | 17.5% | 91.78% | 92.92% |
Last Price | 1781.8 | 1781.8 | 1781.8 | 1781.8 | 1781.8 | 1781.8 | 1781.8 | 1781.8 | 1781.8 |
Trend-Previous Close | 1803.9 | 1693.1 | 1666.35 | 1732.35 | 1756.85 | 1887.75 | 1516.4 | 929.1 | 923.6 |
SUNPHARMA's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
SELL-APPROACHING
returns:
5.24%
(6.91%),
p.close: 1693.1
entry:
1810.04,
exit:
1807.65,
min.ret:
0.13%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.24%
(6.81%),
p.close: 1693.1
entry:
1808.32,
exit:
1819.7,
min.ret:
-0.63%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.24%
(6.02%),
p.close: 1693.1
entry:
1794.94,
exit:
1800.98,
min.ret:
-0.34%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
5.24%
(5.35%),
p.close: 1693.1
entry:
1783.69,
exit:
1783.59,
min.ret:
0.01%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
5.24%
(4.32%),
p.close: 1693.1
entry:
1766.31,
exit:
1763.76,
min.ret:
0.14%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
5.24%
(4.34%),
p.close: 1693.1
entry:
1766.66,
exit:
1767.67,
min.ret:
-0.06%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
SELL-ACTIVE
returns:
6.93%
(6.51%),
p.close: 1666.35
entry:
1774.83,
exit:
1778.25,
min.ret:
-0.19%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
6.93%
(10.29%),
p.close: 1666.35
entry:
1837.87,
exit:
1839.21,
min.ret:
-0.07%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
6.93%
(7.76%),
p.close: 1666.35
entry:
1795.69,
exit:
1780.96,
min.ret:
0.82%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
6.93%
(6.12%),
p.close: 1666.35
entry:
1768.37,
exit:
1756.88,
min.ret:
0.65%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
6.93%
(6.36%),
p.close: 1666.35
entry:
1772.3,
exit:
1773.52,
min.ret:
-0.07%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
returns:
2.85%
(13.15%),
p.close: 1732.35
entry:
1960.17,
exit:
1870.02,
min.ret:
4.6%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
2.85%
(9.65%),
p.close: 1732.35
entry:
1899.45,
exit:
1848.09,
min.ret:
2.7%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
2.85%
(8.09%),
p.close: 1732.35
entry:
1872.43,
exit:
1835.33,
min.ret:
1.98%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
2.85%
(9.87%),
p.close: 1732.35
entry:
1903.27,
exit:
1898.59,
min.ret:
0.25%
Using: 1M trend, 0 Days Left
|
SUNPHARMA's symbol current price is 1781.8 (-1.23%) as on . Yesterday's close was 1803.9. It's return velocities are computed basis data from date .
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Open-High (> 1.0%) | 54.28% | 60.0% | 54.55% | 50.0% | 39.39% | 39.68% | 37.7% |
Open-Low (> 1.0%) | 34.78% | 20.0% | 40.91% | 48.48% | 52.27% | 45.63% | 41.14% |
Open-Close-Up (> 0.5%) | 46.9% | 60.0% | 40.91% | 37.88% | 29.55% | 32.54% | 29.89% |
Open-Close-Down (> 0.5%) | 33.14% | 20.0% | 40.91% | 43.94% | 46.21% | 37.7% | 31.88% |
Low-Close-Up (> 1.0%) | 52.27% | 60.0% | 50.0% | 46.97% | 38.64% | 40.08% | 36.9% |
High-Close-Down (> 1.0%) | 30.84% | 0% | 50.0% | 56.06% | 51.52% | 43.25% | 37.83% |
SUNPHARMA's symbol win percent is computed basis data from date